CHAPTER 11 PROCEEDINGS

Drugmaker Athenex voluntarily files for US Chapter 11 proceedings

Athenex reached an agreement with its lenders to move forward with an expedited sale process of its assets. The assets to be sold would be across its primary businesses of Athenex Pharmaceutical Division (APD), Orascovery, and Cell Therapy.